Delivery Order SPE2DB24D2011-SPE2DB25FBRLD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 1, 2025. This non-set-aside contract represents a single delivery order fulfillment of this pharmaceutical product, which is commonly used for osteoporosis treatment. The award was made to AmerisourceBergen's Corporate Office division, based in Conshohocken, Pennsylvania, where the place of...
- The Defense Logistics Agency awarded a $10,405.72 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The delivery order represents a single transaction under AmerisourceBergen Drug Corp's broader federal contract...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 22, 2025. This non-competitive delivery order represents a single pharmaceutical procurement from the company's extensive federal contract portfolio. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,125.19 on September 12, 2025, with completion scheduled for September 15, 2025. The order covers Forteo 560 mcg/2.24 mL pen injections, a brand-name pharmaceutical product used in osteoporosis treatment. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition to AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $3,803.41 to AmerisourceBergen Drug Corp for the supply of Forteo 560 MCG/2.24 ML pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract represents a direct delivery order for pharmaceutical products to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,601.43 for Forteo (560 mcg/2.24 mL pen injection), a pharmaceutical product used in osteoporosis treatment. This firm fixed-price delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively procured with no...
- The Defense Logistics Agency awarded a $13,965.22 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The contract will be performed at the company's corporate office...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRLDDelivery Order
The Defense Logistics Agency awarded a $54,040.80 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 ml pen injections), a pharmaceutical product used to treat osteoporosis. The contract is a firm fixed price delivery order with no set-aside designation, issued on July 31, 2025, with an ultimate completion date of August 1, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical supply agreement enables AmerisourceBergen to furnish a broad range of medications, medical supplies, and specialty pharmaceuticals to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The delivery order represents a routine transaction within this strategic pharmaceutical prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.0k | 7/31/25 |